Robot-assisted total laparoscopic hysterectomy in obese and morbidly obese women
- 171 Downloads
Total laparoscopic hysterectomy (TLH) in obese patients is challenging. We sought to evaluate whether total laparoscopic hysterectomies using the da Vinci robotic system in obese patients, in comparison with non-obese patients, is a reasonable surgical approach. One-hundred consecutive robot-assisted TLHs were performed over a 17-month period. Obesity was not a contraindication to robotic surgery, assuming adequate respiratory function to tolerate Trendelenburg position and, for cancer cases, a small enough uterus to allow vaginal extraction without morcellation. Data were prospectively collected on patient characteristics, total operative time, hysterectomy time, estimated blood loss, length of stay, and complications. Outcomes with non-obese and obese women were compared. The median age, weight, and BMI of the 100 patients who underwent robot-assisted TLH was 57.6 years (30.0–90.6), 82.1 kg (51.9–159.6), and 30.2 kg/m2 (19.3–60.2), respectively. Fifty (50%) patients were obese (BMI ≥ 30); 22 patients were morbidly obese (BMI ≥ 40). There was no increase in complications (p = 0.56) or blood loss (p = 0.44) with increasing BMI. While increased BMI was associated with longer operative times (p = 0.05), median time increased by only 36 min when comparing non-obese and morbidly obese patients. Median length of stay was one day for all weight categories (p = 0.42). Robot-assisted TLH is feasible and can be safely performed in obese patients. More data are needed to compare robot-assisted TLH with other hysterectomy techniques in obese patients. Nonetheless, our results are encouraging. Robot-assisted total laparoscopic hysterectomy may be the preferred technique for appropriately selected obese patients.
KeywordsRobotics Obesity Obese Hysterectomy Robot-assisted surgery Laparoscopic-assisted hysterectomy Total laparoscopic hysterectomy
Statistical analysis was performed by Vanessa Bolejack, MPH, Cancer Research and Biostatistics, Seattle, WA, USA.
- 1.Centers for Disease Control and Prevention, Hysterectomy in the United States, 2000–2004, http://www.cdc.gov/reproductivehealth/WomensRH/00-04-FS_Hysterectomy.htm. Last accessed online 4/27/2009
- 2.World Health Organization (2000) (PDF). Technical report series 894: Obesity: preventing and managing the global epidemic. World Health Organization, Geneva. Last accessed online 4/27/2009Google Scholar
- 3.Ogden CL, Carroll MD, McDowell MA, Flegal KM (2007) Obesity among adults in the United States—no change since 2003–2004. NCHS data brief no 1. National Center for Health Statistics, HyattsvilleGoogle Scholar
- 4.Centers for Disease Control and Prevention, Overweight and obesity. CDC, Atlanta. Available at: http://www.cdc.gov/nccdphp/dnpa/obesity/index.htm. Last accessed online 4/27/2009
- 9.American Cancer Society (2008) Cancer Facts & Figures 2008. American Cancer Society, AtlantaGoogle Scholar
- 13.Yu CK, Cutner A, Mould T, Olaitan A (2005) Total laparoscopic hysterectomy as a primary surgical treatment for endometrial cancer in morbidly obese women. Br J Obstet Gynaecol 112:115–117Google Scholar
- 15.Beste TM, Nelson KH, Daucher JA (2005) Total laparoscopic hysterectomy utilizing a robotic surgical system. J Soc Laparoendosc Surg 9:13–15Google Scholar
- 19.Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS 31 March 2003 (http://ctep.cancer.gov), Published date 9 August 2006